Summary. Lactic acidosis occourred in 6 metformintreated diabetic patients. Five of them had received 1.6 to 2.4 g metformin per day over a period of weeks or years. Acute renal failure, induced by i. v. pyelography, arteriography, or severe dehydration, preceded lactic acidosis by a few days and apparently precipitated it. The sixth patient had normal renal function prior to taking a massive overdose of metformin in an attempt at suicide. The metabolic pattern was very similar to that observed in phenformin-induced lactic acidosis: severe metabolic acidosis (pH: 7.02 + 0.95; HCO~: 6.3 + 0.9 mmol/l; PaCO2:25 _+ 4mmHg; PaO2:110 + 19 mmHg); hyperlactataemia (18.4 + 3.3 retool/l) and high lactate/pyruvate ratio (51 _+ 5); high blood alanine (2.82 + 1.10 mmol/1); high 3-hydroxybutyrate (15.8 + 3.3 mmol/1) and high 3-hydroxybutyrate/ acetoacetate ratio (26 + 10). Hypoglycaemia (25 to 60 mg per 100 ml) was observed in 4 patients, in spite of high glucagon (760 _+ 148 pg/ml) and low insulin (13 + 5 ~tU/ml) levels. A guanidine substance was characterized in the plasma at concentrations 45 to 110 ~tg/ml; it was similar to metformin and distinct from creatinine, according to chromatographic and other criteria; its concentration in the plasma decreased during dialysis, and the same substance appeared in the dialysis effluent.
From the respective frequency of case reports in medical journals, it seems that metformin-induced lactic acidosis occurs far less frequently than with phenformin. We report 6 diabetic patients with a metformin-induced lactic acidosis, very similar in its clinical and metabolic patterns to that induced by phenformin.
Methods
All patients, hospitalized in various medical departments for several days or weeks prior to the occurrence of lactic acidosis, were admitted to an intensive care unit once the acute metabolic complication had developed. Collection of biological samples and assays for the circulating substrates and hormones were performed as previously published [1] .
Metformin was assayed by a colorimetric method [2] , slightly modified and tested for specificity [1] [2] [3] . This method is based upon the reaction of alphanaphthol-diacetyl with the guanidine group of metformin. Preparation of samples was as previously published [1, 2] and standard curves for metformin were conducted with metformin (Metformin-HC1, Aron Inc., Paris, France) added to normal plasma. Possible interference with other drugs taken by the patients was investigated and the results were negative. Plasma from uraemic patients not treated with metformin did not react in the assay. Further characterization included thin-layer chromatography on Kieselguhr plates (Merck 5729) with chloroformmethanol-ammonia (90/9.9/0.1 v/v) as solvent and the alpha-naphthol-diacetyl staining reagent [4] ; colorimetric reaction with NaC10 M/10 [5] and crystallization in the presence of sodium phenyltetraborate [5] were also performed.
Case Reports
Case 1. Male, diabetic, 49 years, 166 cm, 80 kg; 2.4 g/day metformin was given for one week. Because of hypertension (170-110 mmHg), spironolactone, furosemide, alpha-methyl-dopa and dihydralazine were also prescribed. Serum creatinine was 2.0 mg/100 ml and blood glucose 400 mg/100 ml. I.v. pyelography was performed and the patient became anuric on the following day; administration of metformin was continued for two further days. On admission (three days after the i.v. pyelography) the patient was hypothermic (35.6~ and anuric. Blood pressure was 65--40 mmHg, central venous pressure 9 mmHg and heart rate 75/min. Hypoglycaemia (55 rag/100 ml) accompanied the metabolic acidosis and hyperlactataemia. Glucose (325 g), insulin (10 U), plasma volume expanders (4000 ml) and sodium bicarbonate (425 mmol.) were rapidly administered and haemodialyses subsequently performed 1. The patient improved rapidly and was discharged a fortnight later; serum creatinine at that time was 1.9 mg/100 mi.
Case 2. Male, diabetic, 52 years, 94 kg~ 170 cm; metformin 2.4 g/day was given for 14 months. Hyperlipaemia and hypertension were also present and were treated with propranolol, clonidine, furosemide and clofibrate; serum creatinine, at that time, was 3.6 mg/100 ml. I.v. pyelography was performed and the patient became anuric on the following day. The same dose of metformin was administered for a further 5 days; then lactic acidosis was diagnosed. On admission in the intensive care unit, the patient was deeply comatose, breathing rapidly (32 per minute) and relatively hypotensive (140-80 mmHg); central venous pressure was 5 mmHg, mean pulmonary artery pressure: 8 mmHg, pulmonary capillary pressure: 5 mmHg. Administration of insulin (30 U), glucose (200 g), plasma volume expanders (3750 ml), sodium bicarbonate (1500 mmol) and furosemide (1300 rag) was combined With peritoneal dialysis. The patient recovered from lactic acidosis and acute renal failure, but died following a massive hemiplegia two months later.
Case 3. Female, diabetic, 67 years, 58 kg, 150 cm. Metformin (1.6 g/day) was given over a period of 15 years with the recent addition of glibenclamide 10 mg/24 h. Diabetes mellitus was associated with coronary artery disease and peripheral arterial disease: myocardial infarctions had occurred in 1970 and February 1975 . When hospitalized (April 1975) serum ereatinine was 2.0 mg/100 ml and blood glucose 90 rag/100 ml. Aortography was performed and the patient became anuric within a few hours. Severe hypoglycaemia occurred 24 h later; the giibenclamide was stopped, but not the metformin. The patient remained semicomatose and anuric in spite of administration of plasma volume 1 The various treatments mentioned are those administered during the first 48 h expanders (2300 ml) and furosemide (330 mg). Blood pressure was 150-90 mmHg and central venous pressure 2 mmHg. In spite of repeated haemodialyses, the metabolic acidosis rapidly worsened and a second hypoglycaemic episode occurred (25 mg/100 ml). Serum creatinine at that time was 4.8 rag/100 ml. The mefformin was stopped and haemodialyses were repeated. The patient recovered from acute renal failure and lactic acidosis, but died from myocardial infarction one month later.
Case 4. Female, 66 years, 76 kg, 170 cm. Diabetes mellitus, high blood pressure and hyperlipaemia were diagnosed (1975) following a sudden left hemiplegia. Serum creatinine was 1.1 mg/100 ml and fasting blood glucose 290 mg/100 ml. She was given metformin 1.6 g/day for 10 months; administration of the drug was interrupted on several occasions because of gastric intolerance, then resumed. 240 mg gentamycin per day was added because of an urinary infection. Acute gastroenteritis then induced severe dehydration and anuria. The patient was comatose and polypneic. Blood pressure was 120-90 mmHg, central venous pressure 3 mmHg. Serum creatinine at that time was 3.0 mg/100 ml and blood glucose 45 mg/100 ml. Administration of plasma volume expanders (7000 ml), sodium bicarbonate (560 mmol.) and furosemide (325 mg) was followed by the restoration of urine flow; the patient progressively recovered from acidosis, hyperlactataemia and acute renal failure.
Case 5. Male, diabetic, 38 years, 60 kg, 170 cm. Mefformin 1.6 g/day was given for 6 weeks. He then took 24 g metformin plus phenobarbital and opipramol in an attempt at suicide. He was admitted to hospital 10 h later, deeply comatose, hypothermic (34.5) and anuric; blood pressure was 110-70 mmHg and pulse rate 100/min. Respiratory rate was 20/min. in spite of a deep metabolic acidosis, presumably because of the associated phenobarbital intoxication; concentration of phenobarbital in plasma was 50 ~tg/ml on admission; ethanol, methanol and acetyl salicylic acid were not detectable. Serum creatinine was 0.8 mg per 100 ml. Respiratory assistance was provided; peritoneal dialysis, sodium bicarbonate (1260 mmol.) and furosemide (280 mg) were administered. The patient remained anuric, collapsed and died 30 h after admission. Serum creatinine was 3.0 mg/100 ml before death.
Case 6. Female, diabetic, 65 years, 47 kg, 144 cm; 1.6 g of metformin was given per day over a period of 15 years. Several episodes of gastroenteritis were followed by dehydration. When admitted, the patient was anuric, hypothermic and comatose. Blood pressure was 120-80 mmHg. Blood glucose was 60 mg/100 ml; serum creatinine, which had been 3.1 mg/100 ml some weeks earlier, was 7.5 mg per 100 ml; sodium bicarbonate (600 mmol.), furosemide (500 mg), plasma volume expanders (6000 ml), glucose (50 g ) and insulin (20 U) were given. The patient recovered.
Results
Precipitating Factors (Table 1) All patients had been treated with metformin for weeks to years. Overdosage, due to psychotic behaviour, occurred in patient n ~ 5. Usual doses (1.6 to 2.4 g/day) had been given despite known chronic renal failure in patients n ~ 1, 2, 3, 6.
Acute renal failure was present, on admission, in a Samples for creatinine had been routinely collected a few days before the acute metabolic events b Creatinine was 3.0 mg/100 ml 24 h later all patients (Fig. 1) . I.v. pyelography (patients n ~ 1 and 2), arteriography (patient n ~ 3) or acute dehydration induced by gastroenteritis (patients n ~ 4 and 6) preceded the renal failure. Haemodynamics were not dramatically modified when lactic acidosis was diagnosed, except in patient n ~ 1. The time-relationship between the probable cause for anuria, then renal failure and the appearance of lactic acidosis sug2 gests strongly that in patients n ~ 1, 2, 3, 4, 6 anuria was not the consequence of lactic acidosis but its precipitating cause. In patients n ~ 2 and 6, the first blood samples collected showed a sharp rise of blood lactate. In patient n ~ 5, the shock following overdosage of various drugs seems to have caused anuria and the rise of creatinine, which was initially normal. A cardiopathy and/or a severe angiopathy were present in patients n ~ 1, 2, 3, 4; diuretic or antihypertensive treatment had been recently started in patients n ~ 1 and 2 and gentamycin administered in patient n ~ 4: all possible adjuvant factors for a rise of serum creatinine and a decrease in renal excretion of metformin.
Liver function was normal in all patients includ- 
Metabolic Study
All patients exhibited, on admission, the metabolic criteria for severe metabolic acidosis: mean blood Table 2 . Blood glucose level was low in 4 patients while the 2 others were hyperglycaemic. The high blood lactate concentration (18.4 _+ 3.3 mmol/1) was associated with high L/P ratios (51 ___ 5) and high blood alanine concentrations (2.82 __ 1.10 mmol/1). Hydroxybutyrate level was elevated (15.8 • 3.3 mmol/1) and the ratio hydroxybutyrate/acetoacetate was higher than normal (26 • 10) . This hyperketonaemia contrasted with the moderate increase of free fatty acids (0.63 _+ 0.07 mmol/1). High glucagon values (mean: 760 _ 148 pg/ml) were accompanied by normal or low insulin values (mean 13 + 5 ~tU/ml). As expected from severely stressed patients, growth hormone and cortisol were high, respectively: 11.5 _+ 4.8 ng/ml and 44 + 12 ~tg/100 ml. The time-course of the metabolic disturbances is shown in Figure 2 and detailed for patient n ~ 2 in Table 3 ; blood lactate and alanine did not return to near-normal values before the 4th day of treatment; the decrease in 3-hydroxybutyrate and free fatty acids occurred sooner. An alkaline overshoot was noted on the 4th or 5th day in all the patients who recovered from lactic acidosis.
Guanidine Derivative Results
Plasma samples from patients n ~ 1, 2, 4, 5 revealed high concentrations of an abnormal guanidine derivative ranging from 45 to 110 ~g/ml (Fig. 3) ; this was not investigated in patients n ~ 3 and 6. Plasma from uraemic patients, not treated with metformin, plasmas from metformin-treated subjects with normal renal function, and control peritoneal dialysis fluid yielded undetectable values. Thin-layer chromatography demonstrated RF values identical to that of metformin and different from that of creatinine. The same substance was present in the effluent peritoneal fluid from patient n ~ 2. Repeated measurements demonstrated a progressive decrease in the plasma metformin level during the therapeutic course. Neutralized plasma extracts, in the presence of NaC10 0.1 M, gave the colorimetric reaction of metformin, with a maximal absorption at 380 nm. Crystallization in the presence of sodium-phenyltetraborate yielded hexagonal crystals similar to those obtained with metformin.
Discussion
Only 8 case records of lactic acidosis associated with a metformin treatment exclusive of other biguanides have been published compared with near two hundred published cases of phenformin-associated lactic acidosis [1, [12] [13] [14] [15] [16] . Data derived from [17] indicate that biguanide consumption in France, for 1975, was 92,054 kg metformin and 1,418 kg phenformin; assuming a mean daily intake of 2 g metformin or 0.1 g phenformin per patient, 165000 patients may have been on biguanide therapy in France that year: 76% of them on metformin and 24% on phenforrain, a very different proportion from certain other countries [18, 19] . Metformin is approximately 20 times less active than phenformin [20] ; this much lower hypoglycaemic potency is believed to be due patients with a metformin-induced lactic acidosis. In the patient n~ mefformin was detected in the effluent during peritoneal dialysis, at concentrations of 8 to 12 ~tg/ml. Symbols and curves correspond to patients no. 1 (• no. 2 (A), no. 3 (11) and no. 5
(.)
to differences in lipophilic properties and binding to the mitochondrial membrane [21] [22] [23] , but the mechanism of action seems to be basically the same for both drugs [23] [24] [25] [26] [27] [28] [29] . The metabolic pattern in the present cases was strikingly identical to that observed in phenformin-associated lactic acidosis [1, [12] [13] [14] [15] [16] [30] [31] [32] and experimental phenformin-induced lactic acidosis in rats [33] . If differences do exist between metformin and phenformin regarding the frequency of adverse reactions in patients, these may be related to differences in pharmacokinetics rather than mechanism of action. Metformin is normally very rapidly excreted by the kidney [34, 37] and not metabolized at all by the liver, as distinct from phenformin [38] [39] [40] . Acute renal failure seems to have played a vital role in the precipitation of lactic acidosis in 5 of our patients and in most of the cases published by others (Table  4) . Arteriography, pyelography, i.v. infusion of low molecular weight dextran or large doses of gentamycin, could account for the occurrence of anuria [41] [42] [43] . The hypothesis of metformin accumulation seems strongly supported by the experience of patient n ~ 3 and by the high concentration of biguanide measured in the plasma from patients n ~ 1, 2, 4, 5; concentration in the liver must have been even higher [34] [35] [36] [37] . Acute renal failure may have also reduced the metabolism of lactate by the kidney which, normally, can metabolize up to 30% of a lactate load [44, 45] . This occurred precisely when hepatic gluconeogenesis and lactate uptake by the liver were impaired under the influence of biguanide accumulation, metabolic acidosis and poor haemodynamic state. It has been known for years that metformin is excreted by the kidney: continuation of metformin treatment in spite of anuria can be accounted for by ignorance of the pharmacokinetics of the drug outside the specialised diabetic clinics. Whether chronic renal failure can favour accumulation of metformin and the triggering of lactic acidosis remains unclear from our case records. However since an elevation of serum creatinine occurred readily in association with acute gastroenteritis or diuretic treatment, etc., the long-term prescription of metformin in such patients seems rather hazardous: a chronic elevation of serum creatinine should be a clear indication for not giving metformin.
The therapeutic management proved efficient. since 5 out of 6 patients recovered from the acute metabolic event. Early and massive alkalinization is a possible physiopathological treatment, restoring liver enzymic activities [44, 45] ; this therapy was associated with forced diuresis and dialysis; relatively low amounts of insulin and glucose were administered [46, 47] . Because of the possible risk of pulmonary hypertension [48] , the infusion of large amounts of plasma volume expanders was carried out with concomitant measurements of central venous blood pressure. Two patients died because of secondary vascular complications. Biguanides, as fibrinolytic agents, may be used in patients with impaired cardiovascular and renal status [49] . In such patients, metformin or other biguanides cannot be regarded as mild, harmless drugs. Metformin, like phenformin, buformin [50] , formerly synthaline [51 and 52] and occasionally another guanidine derivative, pentamidine or Lomidine | [53] , can induce lactic acidosis in the presence of renal failure. It must be emphazised that biguanides should not be used in patients with renal failure and that the treatment of diabetes with intercurrent illness is Insulin.
